RenovoRx Inc
NASDAQ:RNXT
RenovoRx Inc
NASDAQ:RNXT
Price:
0.99
USD
-1.98%
Market Cap:
$36.3m
Balance Sheet
Balance Sheet Decomposition
RenovoRx Inc
RenovoRx Inc
Balance Sheet Decomposition is not available for
RenovoRx Inc
RenovoRx Inc
Balance Sheet
RenovoRx Inc
RenovoRx Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
2
|
2
|
15
|
4
|
1
|
7
|
|
| Cash Equivalents |
2
|
2
|
15
|
4
|
1
|
7
|
|
| Short-Term Investments |
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
0
|
1
|
|
| Total Current Assets |
2
|
2
|
16
|
7
|
1
|
8
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
-16%
|
16
+753%
|
7
-55%
|
1
-80%
|
8
+454%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
3
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
4
|
1
|
1
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
3
|
2
|
|
| Total Liabilities |
1
N/A
|
4
+409%
|
1
-77%
|
1
+17%
|
4
+306%
|
4
-18%
|
|
| Equity | |||||||
| Common Stock |
12
|
12
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
11
|
15
|
21
|
31
|
41
|
50
|
|
| Additional Paid In Capital |
0
|
0
|
37
|
37
|
38
|
55
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
N/A
|
15
N/A
|
6
-60%
|
3
N/A
|
4
N/A
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-16%
|
16
+753%
|
7
-55%
|
1
-80%
|
8
+454%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
8
|
8
|
9
|
9
|
11
|
24
|
|
Switch to:
Switch to:
See Also
Discover More
